newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update

Confirms Timing for Primary Outcome Data Readout for two Phase 2 OraGrowtH Trials in Q4 2023Late Breaking Abstract Accepted for Oral Presentation at ESPE 2023Encouraging Interim Data from OraGrowtH Trials Presented at